Nurse Practitioner · Novi, MI
NPI
1750801023
Since 2017
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
39450 W Twelve Mile Rd Ste 200
Novi, MI, 48377
Phone (313) 916-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
367 services
Medicare patients, 2024
183
Average age 69
Drug cost, 2024
$3.1M
4,661 prescriptions
Company payments, 2025
$144
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amy M Bertha was code 99214 (office e&m - established), 223 times for 159 patients. In total Amy M Bertha billed 367 services in 9 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 223 | 159 | $61.26 | $14K |
| 95251 Test - Miscellaneous | Office | 101 | 70 | $21.98 | $2,220 |
| 99215 Office E&M - Established | Office | 24 | 23 | $97.22 | $2,333 |
By year: 2022 $13K for 276 services; 2023 $18K for 353 services; 2024 $19K for 367 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amy M Bertha prescribed most often to Medicare patients was Ozempic (Semaglutide), with 654 prescriptions and refills. In total Amy M Bertha wrote 4,661 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 654 | 1,156 | 161 | $1.0M |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 475 | 1,337 | 190 | $81K |
| Novolog Flexpen Insulin Aspart | 288 | 749 | 129 | $78K |
| Metformin Hcl Generic | 283 | 729 | 95 | $2,694 |
| Jardiance Empagliflozin | 260 | 656 | 96 | $362K |
| Mounjaro Tirzepatide | 250 | 316 | 49 | $316K |
| Trulicity Dulaglutide | 180 | 301 | 49 | $283K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 172 | 439 | 85 | $22K |
| Metformin Hcl Er Metformin Hcl | 156 | 438 | 59 | $2,233 |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 154 | 403 | 69 | $21K |
| Humalog Kwikpen U-100 Insulin Lispro | 134 | 381 | 61 | $43K |
| Levothyroxine Sodium Generic | 133 | 370 | 50 | $1,776 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 103 | 222 | 31 | $83K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 92 | 240 | 49 | $11K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 77 | 199 | 32 | $11K |
Brand drugs: 3,234 claims; generic drugs: 709 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amy M Bertha $144 ($144 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $144.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 2 | $144 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.